Comparison of Fixed-dose Rosiglitazone/Metformin Combination Therapy with Sulphonylurea Plus Metformin in Overweight Individuals with Type 2 Diabetes Inadequately Controlled on Metformin Alone-Reference-Cited by-同舟云学术

Comparison of Fixed-dose Rosiglitazone/Metformin Combination Therapy with Sulphonylurea Plus Metformin in Overweight Individuals with Type 2 Diabetes Inadequately Controlled on Metformin Alone

Published:2007-12-20 Issue:01 Volume:116 Page:6-13
ISSN:0947-7349
Container-title:Experimental and Clinical Endocrinology & Diabetes
language:en
Short-container-title:Exp Clin Endocrinol Diabetes

Author:

Hamann A.,Garcia-Puig J.,Paul G.,Donaldson J.,Stewart M.

Publisher

Georg Thieme Verlag KG

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2007-984441

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress;World Journal of Diabetes;2023-03-15

2. Certain sulfonylurea drugs increase serum free fatty acid in diabetic patients: A systematic review and meta-analysis;World Journal of Clinical Cases;2022-09-16

Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study

;ClinicoEconomics and Outcomes Research;2020-04

4. Cost-Utility Analysis of Saxagliptin/Dapagliflozin Versus Gliclazide and Insulin Glargine: Economic Implications of the Outcomes of the CVD-Real Studies I and II;Health Services Insights;2020-01

5. Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus;Cochrane Database of Systematic Reviews;2019-04-18